Postexposure prophylaxis against experimental inhalation anthrax

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Inhalation anthrax, caused by Bacillus anthracis, is a rare but nearly always fatal disease.
• Effective postexposure prophylaxis strategies are crucial for managing anthrax incidents.

Purpose of the Study:

• To evaluate the efficacy of prolonged postexposure antibiotic treatment, with or without vaccination, against lethal inhalation anthrax in a non-human primate model.
• To determine if antibiotic therapy provides long-term protection after drug discontinuation.

Main Methods:

• Monkeys were exposed to a lethal aerosol dose of Bacillus anthracis.
• Groups received penicillin, ciprofloxacin, doxycycline, doxycycline plus vaccination, vaccination alone, or saline for 30 days.
• Vaccination was administered on days 1 and 15.
• Animals were monitored for survival and protection against rechallenge.

Main Results:

• All antibiotic regimens provided complete protection during treatment.
• Significant long-term protection was observed after antibiotic discontinuation: penicillin (7/10), ciprofloxacin (8/9), doxycycline (9/10), and doxycycline plus vaccination (9/9).
• Control and vaccination-alone groups showed high mortality rates (9/10 and 8/10, respectively).
• Combined postexposure antibiotic treatment and vaccination conferred protection against rechallenge.

Conclusions:

• Prolonged postexposure antibiotic therapy is highly effective in preventing death from inhalation anthrax.
• Antibiotics combined with vaccination provide robust and lasting protection, even after therapy cessation.
• This regimen holds promise for anthrax postexposure prophylaxis.